CADL vs XPEV · $592.0M cap vs rev $895.7M
Candel Therapeutics Inc (CADL) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
Candel Therapeutics Inc (CADL) is a biotechnology company listed on NASDAQ.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US. It is led by Xiaopeng He.
CADL does not have a complete income-statement cache yet.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
CADL currently screens at market cap $592.0M. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the CADL and XPEV stock pages for the full models.
Not investment advice.